Literature DB >> 21457647

Interleukin 12 in cancer treatment.

J Bubeník.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21457647

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN： 0015-5500            Impact factor:   0.906


× No keyword cloud information.
  3 in total

1.  Human interleukin 23 receptor induces cell apoptosis in mammalian cells by intrinsic mitochondrial pathway associated with the down-regulation of RAS/mitogen-activated protein kinase and signal transducers and activators of transcription factor 3 signaling pathways.

Authors:  Wei-Ye Shi; Chang-Yan Che; Li Liu
Journal:  Int J Mol Sci       Date:  2013-12-18       Impact factor: 5.923

2.  Interleukin-12 prevents colorectal cancer liver metastases in mice.

Authors:  Fei Shen; Jiang-Lin Li; Weng-Song Cai; Guang-Hui Zhu; Wei-Li Gu; Lin Jia; Bo Xu
Journal:  Onco Targets Ther       Date:  2013-05-13       Impact factor: 4.147

3.  Tumor growth accelerated by chemotherapy-induced senescent cells is suppressed by treatment with IL-12 producing cellular vaccines.

Authors:  Jana Simova; Olena Sapega; Terezie Imrichova; Ivan Stepanek; Lenka Kyjacova; Romana Mikyskova; Marie Indrova; Jana Bieblova; Jan Bubenik; Jiri Bartek; Zdenek Hodny; Milan Reinis
Journal:  Oncotarget       Date:  2016-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.